IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Pharmacogenetics and Genomics

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on September 3, 2024

Impact Score

2023-2024

1.94

h-Index

2023-2024

 152

Rank

2023-2024

 9602

SJR

2023-2024

 0.563

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Pharmacogenetics and Genomics
Abbreviation Pharmacogenetics Genom.
Publication Type Journal
Subject Area, Categories, Scope Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Genetics (Q3); Genetics (clinical) (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)
h-index 152
Overall Rank/Ranking 9602
SCImago Journal Rank (SJR) 0.563
Impact Score 1.94
Publisher Lippincott Williams and Wilkins Ltd.
Country United States
ISSN 17446880, 17446872
Best Quartile Q1
Coverage History 2005-2023




Aim and Scope


Pharmacogenetics and Genomics is devoted to the rapid publication of research papers, brief review articles and short communications on genetic determinants in response to drugs and other chemicals in humans and animals. The Journal brings together papers from the entire spectrum of biomedical research and science, including biochemistry, bioinformatics, clinical pharmacology, clinical pharmacy, epidemiology, genetics, genomics, molecular biology, pharmacology, pharmaceutical sciences, and toxicology. Under a single cover, the Journal provides a forum for all aspects of the genetics and genomics of host response to exogenous chemicals: from the gene to the clinic.


About Pharmacogenetics and Genomics


Pharmacogenetics and Genomics is a journal covering the technologies/fields/categories related to Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Genetics (Q3); Genetics (clinical) (Q3); Molecular Biology (Q3); Molecular Medicine (Q3). It is published by Lippincott Williams and Wilkins Ltd.. The overall rank of Pharmacogenetics and Genomics is 9602. According to SCImago Journal Rank (SJR), this journal is ranked 0.563. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 152. The best quartile for this journal is Q1.

The ISSN of Pharmacogenetics and Genomics journal is 17446880, 17446872. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Pharmacogenetics and Genomics is cited by a total of 208 articles during the last 3 years (Preceding 2023).


Pharmacogenetics and Genomics Impact IF 2023-2024


The Impact IF 2023 of Pharmacogenetics and Genomics is 1.94, which is computed in 2024 as per its definition. Pharmacogenetics and Genomics IF is decreased by a factor of 0.6 and approximate percentage change is -23.62% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Pharmacogenetics and Genomics Impact IF 2024 Prediction


Impact IF 2023 of Pharmacogenetics and Genomics is 1.94. If the same downward trend persists, Impact IF may fall in 2024 as well.


Impact IF Trend


Year wise Impact IF of Pharmacogenetics and Genomics. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2023 1.94
2022 2.54
2021 1.80
2020 1.56
2019 2.62
2018 3.00
2017 2.54
2016 2.35
2015 3.20
2014 3.84

Pharmacogenetics and Genomics h-index


  Table Setting

Pharmacogenetics and Genomics has an h-index of 152. It means 152 articles of this journal have more than 152 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Pharmacogenetics and Genomics ISSN


The ISSN of Pharmacogenetics and Genomics is 17446880, 17446872. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Pharmacogenetics and Genomics Rank and SCImago Journal Rank (SJR)


The overall rank of Pharmacogenetics and Genomics is 9602. According to SCImago Journal Rank (SJR), this journal is ranked 0.563. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Pharmacogenetics and Genomics by Year


Year SJR
2023/2024 Coming Soon
2023 0.563
2022 0.486
2021 0.385
2020 0.579
2019 0.774
2018 0.808
2017 0.933
2016 1.009
2015 1.254
2014 1.343

Ranking of Pharmacogenetics and Genomics by Year


Year Ranking
2023/2024 Coming Soon
2023 9602
2022 10597
2021 12433
2020 8732
2019 6173
2018 5837
2017 4799
2016 4375
2015 3187
2014 2758

Pharmacogenetics and Genomics Publisher


Table Setting

Pharmacogenetics and Genomics is published by Lippincott Williams and Wilkins Ltd.. It's publishing house is located in United States. Coverage history of this journal is as following: 2005-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Pharmacogenetics and Genomics is Pharmacogenetics Genom.. This abbreviation ('Pharmacogenetics Genom.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Pharmacogenetics and Genomics


If your research field is/are related to Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Genetics (Q3); Genetics (clinical) (Q3); Molecular Biology (Q3); Molecular Medicine (Q3), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Pharmacogenetics and Genomics?

Pharmacogenetics and Genomics latest impact IF is 1.94. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 3.84 (2014) and 1.56 (2020), respectively, in the last 10 years. Moreover, its average IS is 2.54 in the previous 10 years.


What's the SCImago Journal Rank (SJR) of the Pharmacogenetics and Genomics?

The Pharmacogenetics and Genomics has an SJR (SCImago Journal Rank) of 0.563, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.343 in 2014 and the lowest being 0.385 in 2021. Furthermore, the average SJR of the Pharmacogenetics and Genomics over the previous 10-year period stands at 2.54.


What's the latest h-index of the Pharmacogenetics and Genomics?

The latest h-index of the Pharmacogenetics and Genomics is 152.


Who's the publisher of the Pharmacogenetics and Genomics?

The Pharmacogenetics and Genomics is published by the Lippincott Williams and Wilkins Ltd., with its country of publication being the United States.


What's the current ranking of the Pharmacogenetics and Genomics?

The Pharmacogenetics and Genomics is currently ranked 9602 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 2758 in 2014 and its lowest position of 12433 in 2021.


What's the abbreviation or short name for the Pharmacogenetics and Genomics?

The standard ISO4 abbreviation for the Pharmacogenetics and Genomics is Pharmacogenetics Genom..


Is the "Pharmacogenetics and Genomics" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Pharmacogenetics and Genomics is classified as a journal that the Lippincott Williams and Wilkins Ltd. publishes.


What's the scope or major areas of the Pharmacogenetics and Genomics?

The Pharmacogenetics and Genomics encompasses the following areas:

  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  • Genetics
  • Genetics (clinical)
  • Molecular Biology
  • Molecular Medicine

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Pharmacogenetics and Genomics?

The Pharmacogenetics and Genomics is assigned the following International Standard Serial Numbers (ISSN): 17446880, 17446872.


What's the best quartile of the Pharmacogenetics and Genomics?

The best quartile for the Pharmacogenetics and Genomics is Q1 (2023).


What's the coverage history of the Pharmacogenetics and Genomics?

The Pharmacogenetics and Genomics coverage history can be summarized as follows: 2005-2023.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Dermatologia Kliniczna journal 25442 Cornetis 7 0.00
Zeitschrift fur Germanistische Linguistik journal 14988 Walter de Gruyter GmbH 16 0.40
Journal of Field Archaeology journal 5619 Maney Publishing 45 1.64
Journal of International Financial Management and Accounting journal 1921 Wiley-Blackwell Publishing Ltd 45 9.38
Journal of Supply Chain Management journal 587 Wiley-Blackwell 112 12.51
Journal of Classical Sociology journal 15798 SAGE Publications Ltd 30 1.30
Palaeontographica Abteilung B: Palaeophytologie book series 10391 E. Schweizerbart'sche Verlagsbuchhandlung 17 3.43
Biological Procedures Online journal 4092 BioMed Central Ltd 48 3.54
Oral Radiology journal 8912 Springer Japan 23 2.13
Epigenetics journal 3529 Landes Bioscience 111 3.22

Check complete list




Year wise Impact Score (IS) of Pharmacogenetics and Genomics

Impact Score Table

Year Impact Score (IS)
2024/2025 Coming Soon
2023 1.94
2022 2.54
2021 1.80
2020 1.56
2019 2.62
2018 3.00
2017 2.54
2016 2.35
2015 3.20
2014 3.84



Top Journals/Conferences in Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Acta Pharmaceutica Sinica B
Chinese Academy of Medical Sciences | China

Theranostics
Ivyspring International Publisher | Australia

Current Protocols
John Wiley & Sons Inc. | United States

PLoS Neglected Tropical Diseases
Public Library of Science | United States

Life Sciences
Elsevier Inc. | United States

American Journal of Pharmaceutical Education
Elsevier B.V. | United States

Clinical and Translational Science
Wiley-Blackwell Publishing Ltd | United Kingdom

Expert Review of Clinical Pharmacology
Taylor and Francis Ltd. | United Kingdom

Nanotheranostics
Ivyspring International Publishers | Australia

Antibiotics
Multidisciplinary Digital Publishing Institute (MDPI) | Switzerland

See All

Top Journals/Conferences in Genetics

Cell
Elsevier B.V. | United States

Nature Medicine
Nature Research | United Kingdom

Nature Genetics
Nature Publishing Group | United Kingdom

Nature Reviews Genetics
Nature Publishing Group | United Kingdom

Nature Reviews Methods Primers
Springer Nature | United States

Cell Stem Cell
Cell Press | United States

Cell Genomics
Cell Press | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Nature Microbiology
Nature Publishing Group | United Kingdom

Nature Protocols
Nature Publishing Group | United Kingdom

See All

Top Journals/Conferences in Genetics (clinical)

Nature Reviews Genetics
Nature Publishing Group | United Kingdom

Genome Medicine
BioMed Central Ltd | United Kingdom

American Journal of Human Genetics
Cell Press | United States

Genome Research
Cold Spring Harbor Laboratory Press | United States

Annual Review of Genomics and Human Genetics
Annual Reviews Inc. | United States

Genetics in Medicine
Elsevier B.V. | Netherlands

Circulation. Genomic and precision medicine
Lippincott Williams and Wilkins Ltd. | United States

PLoS Genetics
Public Library of Science | United States

npj Genomic Medicine
Nature Publishing Group | United Kingdom

Human Genetics
Springer Verlag | Germany

See All

Top Journals/Conferences in Molecular Biology

Nature Reviews Molecular Cell Biology
Nature Publishing Group | United Kingdom

Cell
Elsevier B.V. | United States

Nature Medicine
Nature Research | United Kingdom

Nature Methods
Nature Publishing Group | United Kingdom

Nature Reviews Genetics
Nature Publishing Group | United Kingdom

Nature Reviews Methods Primers
Springer Nature | United States

Cell Metabolism
Cell Press | United States

Physiological Reviews
American Physiological Society | United States

Cell Research
Nature Publishing Group | United Kingdom

Molecular Cell
Cell Press | United States

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central Ltd | United Kingdom

EMBO Molecular Medicine
Springer | United Kingdom

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Experimental and Molecular Medicine
Korean Society of Med. Biochemistry and Mol. Biology | South Korea

Trends in Molecular Medicine
Elsevier Ltd | United Kingdom

See All